Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.840
+0.050 (1.04%)
At close: Mar 9, 2026, 4:00 PM EDT
4.860
+0.020 (0.41%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Coya Therapeutics Market Cap
Coya Therapeutics has a market cap or net worth of $113.48 million as of March 9, 2026. Its market cap has increased by 10.09% in one year.
Market Cap
113.48M
Enterprise Value
86.18M
1-Year Change
10.09%
Ranking
Category
Stock Price
$4.84
Market Cap Chart
Since the IPO on December 29, 2022, Coya Therapeutics's market cap has increased from $11.84M to $113.48M, an increase of 858.71%. That is a compound annual growth rate of 103.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 112.31M | -7.46% |
| Dec 31, 2025 | 121.36M | 26.77% |
| Dec 31, 2024 | 95.73M | -10.29% |
| Dec 29, 2023 | 106.71M | 769.50% |
| Dec 30, 2022 | 12.27M | 3.68% |
| Dec 29, 2022 | 11.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genelux | 120.01M |
| Inovio Pharmaceuticals | 119.54M |
| Gain Therapeutics | 117.31M |
| Gossamer Bio | 115.89M |
| Oncolytics Biotech | 114.06M |
| Codexis | 111.10M |
| Precision BioSciences | 110.97M |
| Equillium | 107.78M |